RxDoctor Payments Data

Christin Rowe

Physician Assistant · Fairhope, ALNPI 1730129479

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.2% of the total across 670 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 15.7% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$15,898in general payments, 2019–2025

Across 670 payments — averaging $23.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Sun Pharmaceutical Industries Inc.$2K
  • Johnson & Johnson$2K
  • Incyte Corporation$1K
  • Dermavant Sciences, Inc.$1K
  • Novartis$860
  • plus $6K from 32 others

What the payments were for

  • Speaking & faculty fees$8756%
  • Food & beverage$14,65892%
  • Education$3652%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,898 in reported general payments places this provider in the 95th percentile of 846 physician assistant providers in Alabama.

See all physician assistant providers in Alabama

Medicare billing

Part B allowed, 2024
$177,193
Medicare patients
903
Services billed
4,108

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab27$270,587
OtezlaApremilast20$97,066
Clobetasol Propionate319$17,030
Fluorouracil34$2,617
Doxycycline Hyclate80$1,544
Econazole Nitrate14$1,356
Clindamycin Phosphate48$1,263
Triamcinolone Acetonide104$1,203
Ketoconazole67$1,038
Minocycline Hcl29$760
Fluocinonide13$743
Terbinafine Hcl20$362
Hydroxyzine Hcl29$245
Hydrocortisone49$207
Mupirocin17$197

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AmgenOtezla$200$97,06620 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 846 physician assistant providers in Alabama.

Other physician assistant in Fairhope

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →